BGB-A3055
N/A
Report date: 2026/03/14 20:00:17
Base Information
Drug NameBGB-A3055
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeOne Medicines Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesBeigene Guangzhou Biologics Manufacturing Co Ltd
Inactive CompaniesBeOne Medicines Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A